Hippo (HIPO) Competitors

Hippo logo
$25.84 -0.13 (-0.48%)
Closing price 06/18/2026 03:59 PM Eastern
Extended Trading
$25.48 -0.35 (-1.37%)
As of 06/18/2026 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

HIPO vs. SPNT, CLOV, FIHL, PLGO, and SLDE

Should you buy Hippo stock or one of its competitors? MarketBeat compares Hippo with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Hippo include SiriusPoint (SPNT), Clover Health Investments (CLOV), Fidelis Insurance (FIHL), Fidelis Insurance (PLGO), and Slide Insurance (SLDE). These companies are all part of the "insurance" industry.

How does Hippo compare to SiriusPoint?

Hippo (NYSE:HIPO) and SiriusPoint (NYSE:SPNT) are both finance companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk.

Hippo currently has a consensus target price of $38.33, suggesting a potential upside of 48.38%. SiriusPoint has a consensus target price of $28.00, suggesting a potential upside of 22.74%. Given Hippo's stronger consensus rating and higher possible upside, analysts clearly believe Hippo is more favorable than SiriusPoint.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hippo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71
SiriusPoint
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.50

SiriusPoint has higher revenue and earnings than Hippo. SiriusPoint is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hippo$468.60M0.06$57.70M$4.325.98
SiriusPoint$3.21B0.84$459.60M$4.025.67

In the previous week, Hippo had 11 more articles in the media than SiriusPoint. MarketBeat recorded 11 mentions for Hippo and 0 mentions for SiriusPoint. Hippo's average media sentiment score of 0.32 beat SiriusPoint's score of 0.00 indicating that Hippo is being referred to more favorably in the media.

Company Overall Sentiment
Hippo Neutral
SiriusPoint Neutral

43.0% of Hippo shares are owned by institutional investors. Comparatively, 52.8% of SiriusPoint shares are owned by institutional investors. 10.8% of Hippo shares are owned by insiders. Comparatively, 12.2% of SiriusPoint shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Hippo has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market. Comparatively, SiriusPoint has a beta of 0.61, indicating that its stock price is 39% less volatile than the broader market.

Hippo has a net margin of 23.45% compared to SiriusPoint's net margin of 15.38%. SiriusPoint's return on equity of 16.92% beat Hippo's return on equity.

Company Net Margins Return on Equity Return on Assets
Hippo23.45% 12.17% 2.64%
SiriusPoint 15.38%16.92%2.88%

Summary

Hippo beats SiriusPoint on 9 of the 16 factors compared between the two stocks.

How does Hippo compare to Clover Health Investments?

Hippo (NYSE:HIPO) and Clover Health Investments (NASDAQ:CLOV) are both insurance companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, risk, media sentiment, profitability, dividends, analyst recommendations and valuation.

Hippo has a net margin of 23.45% compared to Clover Health Investments' net margin of -2.58%. Hippo's return on equity of 12.17% beat Clover Health Investments' return on equity.

Company Net Margins Return on Equity Return on Assets
Hippo23.45% 12.17% 2.64%
Clover Health Investments -2.58%-16.52%-9.28%

Hippo has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market. Comparatively, Clover Health Investments has a beta of 2.54, meaning that its share price is 154% more volatile than the broader market.

43.0% of Hippo shares are owned by institutional investors. Comparatively, 19.8% of Clover Health Investments shares are owned by institutional investors. 10.8% of Hippo shares are owned by company insiders. Comparatively, 23.5% of Clover Health Investments shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Hippo has higher earnings, but lower revenue than Clover Health Investments. Clover Health Investments is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hippo$468.60M0.06$57.70M$4.325.98
Clover Health Investments$1.92B1.37-$85.55M-$0.12N/A

In the previous week, Hippo had 5 more articles in the media than Clover Health Investments. MarketBeat recorded 11 mentions for Hippo and 6 mentions for Clover Health Investments. Hippo's average media sentiment score of 0.32 beat Clover Health Investments' score of 0.30 indicating that Hippo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hippo
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Clover Health Investments
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Hippo presently has a consensus target price of $38.33, indicating a potential upside of 48.38%. Clover Health Investments has a consensus target price of $3.82, indicating a potential downside of 23.67%. Given Hippo's stronger consensus rating and higher possible upside, equities research analysts plainly believe Hippo is more favorable than Clover Health Investments.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hippo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71
Clover Health Investments
1 Sell rating(s)
3 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Summary

Hippo beats Clover Health Investments on 13 of the 17 factors compared between the two stocks.

How does Hippo compare to Fidelis Insurance?

Fidelis Insurance (NYSE:FIHL) and Hippo (NYSE:HIPO) are both finance companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, institutional ownership, valuation, dividends, analyst recommendations, earnings, profitability and risk.

Hippo has a net margin of 23.45% compared to Fidelis Insurance's net margin of 9.02%. Hippo's return on equity of 12.17% beat Fidelis Insurance's return on equity.

Company Net Margins Return on Equity Return on Assets
Fidelis Insurance9.02% 8.62% 1.62%
Hippo 23.45%12.17%2.64%

Fidelis Insurance has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fidelis Insurance$2.17B1.02$225.50M$2.2110.38
Hippo$468.60M0.06$57.70M$4.325.98

In the previous week, Hippo had 11 more articles in the media than Fidelis Insurance. MarketBeat recorded 11 mentions for Hippo and 0 mentions for Fidelis Insurance. Hippo's average media sentiment score of 0.32 beat Fidelis Insurance's score of -1.16 indicating that Hippo is being referred to more favorably in the news media.

Company Overall Sentiment
Fidelis Insurance Negative
Hippo Neutral

Fidelis Insurance currently has a consensus target price of $21.92, indicating a potential downside of 4.46%. Hippo has a consensus target price of $38.33, indicating a potential upside of 48.38%. Given Hippo's stronger consensus rating and higher probable upside, analysts clearly believe Hippo is more favorable than Fidelis Insurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fidelis Insurance
2 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.13
Hippo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71

82.0% of Fidelis Insurance shares are held by institutional investors. Comparatively, 43.0% of Hippo shares are held by institutional investors. 10.8% of Hippo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Fidelis Insurance has a beta of 0.36, indicating that its stock price is 64% less volatile than the broader market. Comparatively, Hippo has a beta of 1.51, indicating that its stock price is 51% more volatile than the broader market.

Summary

Hippo beats Fidelis Insurance on 11 of the 16 factors compared between the two stocks.

How does Hippo compare to Fidelis Insurance?

Fidelis Insurance (NYSE:PLGO) and Hippo (NYSE:HIPO) are both small-cap insurance companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, media sentiment, analyst recommendations, profitability, institutional ownership and risk.

In the previous week, Hippo had 10 more articles in the media than Fidelis Insurance. MarketBeat recorded 11 mentions for Hippo and 1 mentions for Fidelis Insurance. Fidelis Insurance's average media sentiment score of 0.80 beat Hippo's score of 0.32 indicating that Fidelis Insurance is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fidelis Insurance
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hippo
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Fidelis Insurance has higher revenue and earnings than Hippo. Hippo is trading at a lower price-to-earnings ratio than Fidelis Insurance, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fidelis Insurance$2.50B0.79$225.50M$3.746.13
Hippo$468.60M0.06$57.70M$4.325.98

Fidelis Insurance has a beta of 0.35, meaning that its share price is 65% less volatile than the broader market. Comparatively, Hippo has a beta of 1.51, meaning that its share price is 51% more volatile than the broader market.

82.0% of Fidelis Insurance shares are held by institutional investors. Comparatively, 43.0% of Hippo shares are held by institutional investors. 10.8% of Hippo shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Hippo has a net margin of 23.45% compared to Fidelis Insurance's net margin of 15.33%. Fidelis Insurance's return on equity of 14.44% beat Hippo's return on equity.

Company Net Margins Return on Equity Return on Assets
Fidelis Insurance15.33% 14.44% 2.63%
Hippo 23.45%12.17%2.64%

Fidelis Insurance currently has a consensus target price of $24.33, suggesting a potential upside of 6.15%. Hippo has a consensus target price of $38.33, suggesting a potential upside of 48.38%. Given Hippo's stronger consensus rating and higher possible upside, analysts plainly believe Hippo is more favorable than Fidelis Insurance.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fidelis Insurance
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
2.60
Hippo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71

Summary

Hippo beats Fidelis Insurance on 9 of the 16 factors compared between the two stocks.

How does Hippo compare to Slide Insurance?

Hippo (NYSE:HIPO) and Slide Insurance (NASDAQ:SLDE) are both small-cap insurance companies, but which is the better stock? We will compare the two companies based on the strength of their profitability, analyst recommendations, valuation, institutional ownership, media sentiment, dividends, earnings and risk.

Hippo currently has a consensus price target of $38.33, indicating a potential upside of 48.38%. Slide Insurance has a consensus price target of $24.80, indicating a potential upside of 49.58%. Given Slide Insurance's stronger consensus rating and higher possible upside, analysts clearly believe Slide Insurance is more favorable than Hippo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hippo
0 Sell rating(s)
3 Hold rating(s)
3 Buy rating(s)
1 Strong Buy rating(s)
2.71
Slide Insurance
0 Sell rating(s)
2 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.89

43.0% of Hippo shares are held by institutional investors. 10.8% of Hippo shares are held by insiders. Comparatively, 50.8% of Slide Insurance shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Slide Insurance has a net margin of 38.86% compared to Hippo's net margin of 23.45%. Slide Insurance's return on equity of 48.38% beat Hippo's return on equity.

Company Net Margins Return on Equity Return on Assets
Hippo23.45% 12.17% 2.64%
Slide Insurance 38.86%48.38%17.38%

In the previous week, Slide Insurance had 2 more articles in the media than Hippo. MarketBeat recorded 13 mentions for Slide Insurance and 11 mentions for Hippo. Hippo's average media sentiment score of 0.32 beat Slide Insurance's score of 0.26 indicating that Hippo is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hippo
3 Very Positive mention(s)
3 Positive mention(s)
5 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Slide Insurance
7 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Slide Insurance has higher revenue and earnings than Hippo. Slide Insurance is trading at a lower price-to-earnings ratio than Hippo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hippo$468.60M0.06$57.70M$4.325.98
Slide Insurance$1.16B1.64$443.96M$3.604.61

Summary

Slide Insurance beats Hippo on 11 of the 15 factors compared between the two stocks.

Get Hippo News Delivered to You Automatically

Sign up to receive the latest news and ratings for HIPO and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HIPO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HIPO vs. The Competition

MetricHippoINS IndustryFinance SectorNYSE Exchange
Market Cap$26.87M$20.94B$13.91B$23.18B
Dividend YieldN/A3.23%5.75%4.07%
P/E Ratio5.9810.4920.1731.61
Price / Sales0.061.65143.7522.82
Price / Cash72.2812.8319.4324.10
Price / Book1.522.642.254.68
Net Income$57.70M$1.89B$1.14B$1.08B
7 Day Performance1.25%-0.54%-0.51%-0.82%
1 Month Performance-0.41%-0.41%2.03%3.12%
1 Year Performance-10.94%0.81%22.33%24.66%

Hippo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HIPO
Hippo
4.681 of 5 stars
$25.84
-0.5%
$38.33
+48.4%
-10.9%$26.87M$468.60M5.98620
SPNT
SiriusPoint
3.1699 of 5 stars
$22.22
+1.7%
$28.00
+26.0%
+18.2%$2.61B$3.21B5.521,099
CLOV
Clover Health Investments
1.4612 of 5 stars
$4.19
+6.9%
$3.23
-22.8%
+68.4%$2.23B$1.92BN/A680
FIHL
Fidelis Insurance
1.9304 of 5 stars
$22.08
+1.2%
$21.92
-0.7%
+44.0%$2.13B$2.17B9.9977
PLGO
Fidelis Insurance
4.145 of 5 stars
$22.46
+1.7%
$24.33
+8.3%
N/A$1.94B$2.50B6.02N/A

Related Companies and Tools


This page (NYSE:HIPO) was last updated on 6/19/2026 by MarketBeat.com Staff.
From Our Partners